Raul Santos MD, MhD, MSc is associate professor and director of the Lipid Clinic at Heart Institute (InCor) University of Sao Paulo Medical School Hospital in Sao Paulo Brazil. His main research lines are genetic dyslipidemias, imaging in atherosclerosis, biomarkers, MASLD and lipid lowering drugs. He’s a highly cited researcher in the field of cross-field (2021-2023) according to Clarivate Analytics, has authored more than 450 papers and many national and international preventive cardiology guidelines. He is a past president of the International Atherosclerosis Society , is the vice president of the Iberoamerican FH Network and member of EAS’ FHSC steering committee.

Contributions

Debate: Coronary Artery Calcification is Primary Prevention (Pro/Con)92nd EAS Congress 2024ASPC-EAS joint sessionPanel Discussion: IAS/EAS joint session - Cardiometabolic traits - The next battleground in Atherosclerosis91st EAS Congress 2023IAS/EAS joint session - Cardiometabolic traits - The next battleground in AtherosclerosisThe patient with high Triglycerides - What should we do now91st EAS Congress 2023IAS/EAS joint session - Cardiometabolic traits - The next battleground in AtherosclerosisPanel Discussion: WHF Cholesterol Roadmap - Cholesterol Lowering Throughout the Life-course91st EAS Congress 2023WHF Cholesterol Roadmap- Cholesterol Lowering Throughout the Life-courseCurrent Roadblocks and Potential Solutions91st EAS Congress 2023WHF Cholesterol Roadmap- Cholesterol Lowering Throughout the Life-courseIAS/EAS joint session - What is the environment doing to our health? - Discussion and Q&A90th EAS Congress 2022IAS/EAS joint session - What is the environment doing to our health?WHF Session 1: WHF Roadmap on Cholesterol update - Discussion and Q&A90th EAS Congress 2022WHF Session 1: WHF Roadmap on Cholesterol updateImplementation today’s key concepts90th EAS Congress 2022WHF Session 1: WHF Roadmap on Cholesterol update